NASDAQ:BEAM (Beam Therapeutics Inc.)

About BEAM

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing.
  • Beam Therapeutics Inc. (NASDAQ: BEAM) Latest News

    No posts found.